Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haynes

Showing results (261-270 of 843) with videos related to

Pageof 85
Sort By:
Expert Review of Vaccines|August 3, 2004
Centralized immunogens as a vaccine strategy to overcome HIV-1 diversityFeng Gao, Bette T Korber, Eric Weaver, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycinM S Hershfield, J Kurtzberg, E Harden, et al.
Environmental Entomology|February 21, 2008
Pheromone trap for the eastern tent caterpillar mothKenneth F Haynes, John McLaughlin, Shelby Stamper, et al.
Acta Crystallographica. Section F, Structural Biology Communications|May 7, 2015
Production, purification and crystallization of a trans-sialidase from Trypanosoma vivaxCarole L F Haynes, Paul Ameloot, Han Remaut, et al.
Journal of Virology|December 14, 2011
High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infectionChristy L Lavine, Socheata Lao, David C Montefiori, et al.
International Journal of Mass Spectrometry|August 24, 2011
Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine CandidateEden P Go, Geetha S Hewawasam, Ben J Ma, et al.
AIDS Research and Human Retroviruses|February 1, 1995
HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogenB F Haynes, M A Moody, C S Heinley, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodiesMikyung Kim, Zhi-Song Qiao, David C Montefiori, et al.
International Immunology|February 1, 1995
Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulatedD D Patel, L P Hale, L P Whichard, et al.
Frontiers in Microbiology|July 6, 2018
Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 InfectionNaveen K Vaidya, Ruy M Ribeiro, Pinghuang Liu, et al.
Pageof 85

Showing results (261-270 of 843) with videos related to

Sort By:
Pageof 85
Expert Review of Vaccines|August 3, 2004
Centralized immunogens as a vaccine strategy to overcome HIV-1 diversityFeng Gao, Bette T Korber, Eric Weaver, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycinM S Hershfield, J Kurtzberg, E Harden, et al.
Environmental Entomology|February 21, 2008
Pheromone trap for the eastern tent caterpillar mothKenneth F Haynes, John McLaughlin, Shelby Stamper, et al.
Acta Crystallographica. Section F, Structural Biology Communications|May 7, 2015
Production, purification and crystallization of a trans-sialidase from Trypanosoma vivaxCarole L F Haynes, Paul Ameloot, Han Remaut, et al.
Journal of Virology|December 14, 2011
High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infectionChristy L Lavine, Socheata Lao, David C Montefiori, et al.
International Journal of Mass Spectrometry|August 24, 2011
Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine CandidateEden P Go, Geetha S Hewawasam, Ben J Ma, et al.
AIDS Research and Human Retroviruses|February 1, 1995
HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogenB F Haynes, M A Moody, C S Heinley, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodiesMikyung Kim, Zhi-Song Qiao, David C Montefiori, et al.
International Immunology|February 1, 1995
Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulatedD D Patel, L P Hale, L P Whichard, et al.
Frontiers in Microbiology|July 6, 2018
Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 InfectionNaveen K Vaidya, Ruy M Ribeiro, Pinghuang Liu, et al.
Pageof 85